TY - JOUR
T1 - Hereditary ataxias
AU - Evidente, Virgilio Gerald H.
AU - Gwinn-Hardy, Katrina A.
AU - Caviness, John N.
AU - Oilman, Sid
PY - 2000
Y1 - 2000
N2 - There are many causes of hereditary ataxia. These can be grouped into categories of autosomal recessive, autosomal dominant, and X-linked. Molecularly, many of them are due to trinucleotide repeat expansions. In Friedreich ataxia, the trinucleotide repeat expansions lead to a 'loss of function.' In the dominant ataxias, the expanded repeats lead to a 'gain of function,' most likely through accumulation of intranuclear (and less commonly cytoplasmic) polyglutamine inclusions. Channelopathies can also lead to ataxia, especially episodic ataxia. Although phenotypic characteristics are an aid to the clinician, a definitive diagnosis is usually made only through genotypic or molecular studies. Genetic counseling is necessary for the testing of symptomatic and asymptomatic individuals. No effective treatment is yet available for most ataxic syndromes, except for ataxia with isolated vitamin E deficiency and the episodic ataxias.
AB - There are many causes of hereditary ataxia. These can be grouped into categories of autosomal recessive, autosomal dominant, and X-linked. Molecularly, many of them are due to trinucleotide repeat expansions. In Friedreich ataxia, the trinucleotide repeat expansions lead to a 'loss of function.' In the dominant ataxias, the expanded repeats lead to a 'gain of function,' most likely through accumulation of intranuclear (and less commonly cytoplasmic) polyglutamine inclusions. Channelopathies can also lead to ataxia, especially episodic ataxia. Although phenotypic characteristics are an aid to the clinician, a definitive diagnosis is usually made only through genotypic or molecular studies. Genetic counseling is necessary for the testing of symptomatic and asymptomatic individuals. No effective treatment is yet available for most ataxic syndromes, except for ataxia with isolated vitamin E deficiency and the episodic ataxias.
UR - http://www.scopus.com/inward/record.url?scp=0034021172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034021172&partnerID=8YFLogxK
U2 - 10.4065/75.5.475
DO - 10.4065/75.5.475
M3 - Review article
C2 - 10807077
AN - SCOPUS:0034021172
SN - 0025-6196
VL - 75
SP - 475
EP - 490
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 5
ER -